{
    "code": "12009976",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=12009976",
    "time": "2018-01-12 03:40:27",
    "許可證字號": "內衛藥製字第009976號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/12\/31",
    "發證日期": "59\/09\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY01200997603",
    "中文品名": "利痛保錠",
    "英文品名": "RELAPAL TABLETS",
    "適應症": "骨骼肌各種疼痛痙攣、挫傷",
    "劑型": "110錠劑",
    "包裝": "30.100等粒瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "CHLORMEZANONE"
    ],
    "限制項目": "",
    "申請商名稱": "0201504200  人人化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0201504300  人人化學製藥股份有限公司中壢廠",
        "製造廠廠址": "桃園市中壢區南園二路３號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1220000400",
            "成分名稱": "CHLORMEZANONE",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}